Incidental Discovery of Hepatocellular Carcinoma on 18F-PSMA PET CT Performed for Prostate Cancer Reassessment
Prostate-specific membrane antigen positron emission tomography (PSMA PET) has been approved by the Food and Drug Administration (FDA) to identify prostate cancer in the setting of biochemical recurrence but can also identify other malignancies. 18F-PSMA PET has not been studied as a potential tool...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Case Reports in Surgery |
Online Access: | http://dx.doi.org/10.1155/2023/1458175 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832546707041157120 |
---|---|
author | Lauren Hekman Eva Napierkowski Natalie C. Hartman Jeffrey L. Ellis Robert H. Wagner Davide Bova Maria M. Picken Robert C. Flanigan |
author_facet | Lauren Hekman Eva Napierkowski Natalie C. Hartman Jeffrey L. Ellis Robert H. Wagner Davide Bova Maria M. Picken Robert C. Flanigan |
author_sort | Lauren Hekman |
collection | DOAJ |
description | Prostate-specific membrane antigen positron emission tomography (PSMA PET) has been approved by the Food and Drug Administration (FDA) to identify prostate cancer in the setting of biochemical recurrence but can also identify other malignancies. 18F-PSMA PET has not been studied as a potential tool for hepatocellular carcinoma (HCC). We describe the case of a 76-year-old male with a rising prostate-specific antigen (PSA) after definitive prostate cancer treatment and no prior liver pathology who was incidentally found to have HCC on 18F-PSMA PET. |
format | Article |
id | doaj-art-f0ecd75cb2444d5c8428a5a03057b9f1 |
institution | Kabale University |
issn | 2090-6919 |
language | English |
publishDate | 2023-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Surgery |
spelling | doaj-art-f0ecd75cb2444d5c8428a5a03057b9f12025-02-03T06:47:29ZengWileyCase Reports in Surgery2090-69192023-01-01202310.1155/2023/1458175Incidental Discovery of Hepatocellular Carcinoma on 18F-PSMA PET CT Performed for Prostate Cancer ReassessmentLauren Hekman0Eva Napierkowski1Natalie C. Hartman2Jeffrey L. Ellis3Robert H. Wagner4Davide Bova5Maria M. Picken6Robert C. Flanigan7Loyola University Medical CenterLoyola University Medical CenterLoyola University Medical CenterLoyola University Medical CenterLoyola University Medical CenterLoyola University Medical CenterLoyola University Medical CenterLoyola University Medical CenterProstate-specific membrane antigen positron emission tomography (PSMA PET) has been approved by the Food and Drug Administration (FDA) to identify prostate cancer in the setting of biochemical recurrence but can also identify other malignancies. 18F-PSMA PET has not been studied as a potential tool for hepatocellular carcinoma (HCC). We describe the case of a 76-year-old male with a rising prostate-specific antigen (PSA) after definitive prostate cancer treatment and no prior liver pathology who was incidentally found to have HCC on 18F-PSMA PET.http://dx.doi.org/10.1155/2023/1458175 |
spellingShingle | Lauren Hekman Eva Napierkowski Natalie C. Hartman Jeffrey L. Ellis Robert H. Wagner Davide Bova Maria M. Picken Robert C. Flanigan Incidental Discovery of Hepatocellular Carcinoma on 18F-PSMA PET CT Performed for Prostate Cancer Reassessment Case Reports in Surgery |
title | Incidental Discovery of Hepatocellular Carcinoma on 18F-PSMA PET CT Performed for Prostate Cancer Reassessment |
title_full | Incidental Discovery of Hepatocellular Carcinoma on 18F-PSMA PET CT Performed for Prostate Cancer Reassessment |
title_fullStr | Incidental Discovery of Hepatocellular Carcinoma on 18F-PSMA PET CT Performed for Prostate Cancer Reassessment |
title_full_unstemmed | Incidental Discovery of Hepatocellular Carcinoma on 18F-PSMA PET CT Performed for Prostate Cancer Reassessment |
title_short | Incidental Discovery of Hepatocellular Carcinoma on 18F-PSMA PET CT Performed for Prostate Cancer Reassessment |
title_sort | incidental discovery of hepatocellular carcinoma on 18f psma pet ct performed for prostate cancer reassessment |
url | http://dx.doi.org/10.1155/2023/1458175 |
work_keys_str_mv | AT laurenhekman incidentaldiscoveryofhepatocellularcarcinomaon18fpsmapetctperformedforprostatecancerreassessment AT evanapierkowski incidentaldiscoveryofhepatocellularcarcinomaon18fpsmapetctperformedforprostatecancerreassessment AT nataliechartman incidentaldiscoveryofhepatocellularcarcinomaon18fpsmapetctperformedforprostatecancerreassessment AT jeffreylellis incidentaldiscoveryofhepatocellularcarcinomaon18fpsmapetctperformedforprostatecancerreassessment AT roberthwagner incidentaldiscoveryofhepatocellularcarcinomaon18fpsmapetctperformedforprostatecancerreassessment AT davidebova incidentaldiscoveryofhepatocellularcarcinomaon18fpsmapetctperformedforprostatecancerreassessment AT mariampicken incidentaldiscoveryofhepatocellularcarcinomaon18fpsmapetctperformedforprostatecancerreassessment AT robertcflanigan incidentaldiscoveryofhepatocellularcarcinomaon18fpsmapetctperformedforprostatecancerreassessment |